Marx N, Federici M, Schuett K, Mueller-Wieland D, Ajjan RA, Antunes MJ, et al
Among individuals with both obesity and diabetes, MASLD prevalence reaches 73%, but, importantly, it also affects 57% of individuals with T2D with normal body mass index (BMI) [11]
10.1016/j.clnesp.2020.03.008 Clin Nutr ESPEN 51
These aren't distant possibilitiesthey're immediate threats to your health and longevity
Patients without insurance pay the same rates as insured patientsin many cases, lower than insurance copays for brand-name medications
Her publications provide background for biochemistry-oriented discussion of melanocortin receptor families while keeping the page focused on research documentation, supplier review, and published literature boundaries